225 related articles for article (PubMed ID: 28881212)
1. Nanofiltration as tertiary treatment method for removing trace pharmaceutically active compounds in wastewater from wastewater treatment plants.
Garcia-Ivars J; Martella L; Massella M; Carbonell-Alcaina C; Alcaina-Miranda MI; Iborra-Clar MI
Water Res; 2017 Nov; 125():360-373. PubMed ID: 28881212
[TBL] [Abstract][Full Text] [Related]
2. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
[TBL] [Abstract][Full Text] [Related]
3. Evidence of solute-solute interactions and cake enhanced concentration polarization during removal of pharmaceuticals from urban wastewater by nanofiltration.
Azaïs A; Mendret J; Petit E; Brosillon S
Water Res; 2016 Nov; 104():156-167. PubMed ID: 27522026
[TBL] [Abstract][Full Text] [Related]
4. Removal of pharmaceutically active compounds from water sources using nanofiltration and reverse osmosis membranes: Comparison of removal efficiencies and in-depth analysis of rejection mechanisms.
Matin A; Jillani SMS; Baig U; Ihsanullah I; Alhooshani K
J Environ Manage; 2023 Jul; 338():117682. PubMed ID: 37003228
[TBL] [Abstract][Full Text] [Related]
5. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
6. Effects of water matrix on the rejection of neutral pharmaceutically active compound by thin-film composite nanofiltration and reverse osmosis membranes.
Shah IA; Ali S; Yang Z; Ihsanullah I; Huang H
Chemosphere; 2022 Sep; 303(Pt 3):135211. PubMed ID: 35660049
[TBL] [Abstract][Full Text] [Related]
7. Influences of solution chemistry and polymeric natural organic matter on the removal of aquatic pharmaceutical residuals by nanofiltration.
Zazouli MA; Susanto H; Nasseri S; Ulbricht M
Water Res; 2009 Jul; 43(13):3270-80. PubMed ID: 19520413
[TBL] [Abstract][Full Text] [Related]
8. Application of nanofiltration for the removal of carbamazepine, diclofenac and ibuprofen from drinking water sources.
Vergili I
J Environ Manage; 2013 Sep; 127():177-87. PubMed ID: 23708199
[TBL] [Abstract][Full Text] [Related]
9. Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications.
Xu P; Drewes JE; Bellona C; Amy G; Kim TU; Adam M; Heberer T
Water Environ Res; 2005; 77(1):40-8. PubMed ID: 15765934
[TBL] [Abstract][Full Text] [Related]
10. Impact of feed water pH and membrane material on nanofiltration of perfluorohexanoic acid in aqueous solution.
Zeng C; Tanaka S; Suzuki Y; Fujii S
Chemosphere; 2017 Sep; 183():599-604. PubMed ID: 28575703
[TBL] [Abstract][Full Text] [Related]
11. Rejection of pharmaceutically-based N-nitrosodimethylamine precursors using nanofiltration.
Woods GC; Sadmani AHMA; Andrews SA; Bagley DM; Andrews RC
Water Res; 2016 Apr; 93():179-186. PubMed ID: 26905796
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutically active compounds: Their removal during slow sand filtration and their impact on slow sand filtration bacterial removal.
D'Alessio M; Yoneyama B; Kirs M; Kisand V; Ray C
Sci Total Environ; 2015 Aug; 524-525():124-35. PubMed ID: 25889551
[TBL] [Abstract][Full Text] [Related]
13. Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase enzymes.
Naghdi M; Taheran M; Brar SK; Kermanshahi-Pour A; Verma M; Surampalli RY
Environ Pollut; 2018 Mar; 234():190-213. PubMed ID: 29175684
[TBL] [Abstract][Full Text] [Related]
14. Impacts of biofouling on the removal of pharmaceutically active compounds by a nanofiltration membrane.
Yang Y; Li C; Hou LA
Environ Sci Pollut Res Int; 2019 Oct; 26(30):30575-30583. PubMed ID: 29273979
[TBL] [Abstract][Full Text] [Related]
15. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
[TBL] [Abstract][Full Text] [Related]
16. Influence of activated carbon preloading by EfOM fractions from treated wastewater on adsorption of pharmaceutically active compounds.
Hu J; Shang R; Heijman B; Rietveld L
Chemosphere; 2016 May; 150():49-56. PubMed ID: 26891356
[TBL] [Abstract][Full Text] [Related]
17. Optimization of coagulation with ferric chloride as a pretreatment for fouling reduction during nanofiltration of rendering plant secondary effluent.
Racar M; Dolar D; Špehar A; Kraš A; Košutić K
Chemosphere; 2017 Aug; 181():485-491. PubMed ID: 28460295
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmaceutical micropollutants on the membrane fouling of a submerged MBR treating municipal wastewater: case of continuous pollution by carbamazepine.
Li C; Cabassud C; Reboul B; Guigui C
Water Res; 2015 Feb; 69():183-194. PubMed ID: 25481077
[TBL] [Abstract][Full Text] [Related]
19. Effect of silica fouling on the removal of pharmaceuticals and personal care products by nanofiltration and reverse osmosis membranes.
Lin YL; Chiou JH; Lee CH
J Hazard Mater; 2014 Jul; 277():102-9. PubMed ID: 24560524
[TBL] [Abstract][Full Text] [Related]
20. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes.
Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
Water Res; 2009 May; 43(9):2349-62. PubMed ID: 19303127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
